CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 13 shares at $7.62 ($99)
- 4 Open-market sale Chief Development Officer sold 23 shares at $7.62 ($175)
- 4 Open-market sale Chief Commercial Officer sold 25 shares at $7.62 ($191)
- 4 Open-market sale President & CEO sold 189 shares at $7.62 ($1,440)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 50 shares at $7.62 ($381)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 1,144 shares (option exercise)
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 142,045 shares at $7.04 ($999,997)
- 4 Open-market buy Director bought 18,373 shares at an average $6.06 ($111,425)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 3,488,372 shares at $0.43 ($1,500,000)
Page 4 of 31 · 602 filings